Matthew Outten

Corporate Officer/Principal chez BRIDGEBIO PHARMA, INC.

51 ans

Health Technology

Consumer Services

Profil

Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.

Postes actifs de Matthew Outten

Sociétés	Poste	Début
BRIDGEBIO PHARMA, INC.	Corporate Officer/Principal	01/02/2019
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Corporate Officer/Principal	-

Tous les postes actifs de Matthew Outten

Anciens postes connus de Matthew Outten

Sociétés	Poste	Fin
PHARMACYCLICS, INC.	Corporate Officer/Principal	-

Voir l'expérience en détail de Matthew Outten

Formation de Matthew Outten

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Matthew Outten

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis	Health Technology
Hamilton College (New York) Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Delaware University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Health Technology
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients	Health Technology